Xilinx Rises On Unusually High Volume (XLNX)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Xilinx (Nasdaq: XLNX) is trading at unusually high volume Friday with 5.2 million shares changing hands. It is currently at two times its average daily volume and trading up 75 cents (+2.1%) at $37.19 as of 2:30 p.m. ET.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Xilinx has a market cap of $9.45 billion and is part of the technology sector and electronics industry. Shares are up 1.6% year to date as of the close of trading on Thursday.

Xilinx, Inc. designs, develops, and markets programmable platforms worldwide. The company has a P/E ratio of 19.6, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Xilinx as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. You can view the full Xilinx Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

Take Xilinx' Rally Seriously

Are the Semis Now on Shaky Ground?

Are the Semis Now on Shaky Ground?

Xilinx, Arena Pharmaceuticals, Magellan Midstream: 'Mad Money' Lightning Round

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)